Agreement follows positive NICE recommendation and commits to deliver Leqvio® (inclisiran) access via a population health management approach identifying eligible patients across England1 Over three years ~300,000 patients at high risk of a second cardiovascular event are expected to be treated with inclisiran, a small interfering RNA therapy administered as a […]
Other News
Caladrius Biosciences Announces Appointment of Kristen K. Buck, M.D., as Chief Medical Officer
BASKING RIDGE, N.J., Sept. 01, 2021 (GLOBE NEWSWIRE) — Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a clinical-stage biopharmaceutical company dedicated to the development of cellular therapies designed to reverse disease, today announced the appointment of Dr. Kristen K. Buck as the Company’s Chief Medical Officer (“CMO”). Dr. […]
First Patients in Canada Treated With Cardiovascular Systems, Inc. Diamondback 360® Coronary Orbital Atherectomy System
Introduction of Orbital Atherectomy in Canada Expands Treatment Options for Patients with Complex Coronary Artery Disease ST. PAUL, Minn.–(BUSINESS WIRE)–Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, announced today that the first patients […]
LifeTech Scientific Corporation Announces 2021 Interim Results
SHENZHEN, China, Aug. 30, 2021 /PRNewswire/ — LifeTech Scientific Corporation (LifeTech, 01302.HK), a leading company specialized in minimally invasive interventional medical devices for cardio-cerebrovascular and peripheral vascular diseases, today announced 2021 interim results. Compared with the first half of 2020, LifeTech achieved an outstanding performance. The revenue was approximately RMB461.1 million, increased by approximately 68.9%, the […]
Nicklaus Children’s Hospital Earns National Recognition For Efforts To Improve Cardiac Arrest Survival In Neonates And Infants
MIAMI, Aug. 31, 2021 /PRNewswire/ — Nicklaus Children’s Hospital has received the American Heart Association’s Get With The Guidelines® – Resuscitation Quality Gold Achievement Award in the neonate and infant category for a second year in a row, due to its commitment to treating in-hospital cardiac arrest, and ultimately helping to improve patient survival […]
Arise Vascular Opens First Outpatient Cardiovascular Center in Lafayette, La.
Arise Vascular opens Cardiovascular Surgery Center to bring high-quality, high-value, outpatient cardiovascular procedures to the area. AUSTIN, Texas, Aug. 30, 2021 /PRNewswire/ — Lafayette, Louisiana is getting its first outpatient cardiovascular surgery center, bringing a new level of convenience, cost savings and state-of-the art care to the area. That’s because Austin, Texas-based Arise Vascular has opened the Cardiovascular Surgery […]
Natera Announces the Validation and Launch of the Prospera™ Heart Transplant Assessment Test
Prospera Heart identifies rejection with exceptional performance from a single test, eliminating the need to combine two tests for each patient AUSTIN, Texas, Aug. 31, 2021 /PRNewswire/ — Natera, Inc. (NASDAQ: NTRA), a leader in transforming care through genetic and cell-free DNA (cfDNA) testing, today announced the validation and clinical availability of its Prospera Heart […]
HeartCare Medical Announces 2021 Interim Results
Commercialized Products is Allowed to be Sold in Most of the Provinces in China Continue to Grow Sales of a Product Suite of Stroke Thrombectomy Devices HONG KONG, Aug. 31, 2021 /PRNewswire/ — Shanghai HeartCare Medical Technology Corporation Limited (“HeartCare Medical” or the “Company“, together with its subsidiaries, the “Group“, stock code: 6609), […]
BioSig Confirmed as a Participant of The Mark E. Josephson Twenty-Eight Annual State-of-the-Art Arrhythmia Virtual Symposium
Physician-only event, organized by the University of Pennsylvania, is a tribute to the pioneer of cardiac electrophysiology Westport, CT, Aug. 31, 2021 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (Nasdaq: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative signal processing platform designed to improve signal fidelity and […]
Amarin Reports Overview of Latest Clinical Research Evaluating VASCEPA®/VAZKEPA (Icosapent Ethyl) and Eicosapentaenoic Acid (EPA) Presented at ESC Congress 2021, Organized by the European Society of Cardiology
VASCEPA/VAZKEPA found in prespecified and post hoc analyses to reduce first and total primary endpoints by 26% and 35%, respectively, in REDUCE-IT patients with prior Myocardial Infarction 2021 ESC Guidelines on Cardiovascular Disease Prevention now include VAZKEPA in their recommendations, marking 20th inclusion in global medical societies’ guidelines DUBLIN, Ireland […]